Biomedtech News
Truffle Capital Raises € 250m Fund to Launch Life Science Startups
Affluent Medical announces first patient implanted in optimise II pivotal clinical study for Kalios, the minimally invasive mitral valve repair ring
Carbios receives € 1.4M from ADEME following the success of the first milestone of its CE-PET research project
Abivax Receives French Regulatory Authority (ANSM) Approval to Include French Study Sites in its Phase 2b Ulcerative Colitis Clinical Trial and Provides a Progress Update of the ABX464 Clinical Development Plan in other Inflammatory Diseases
Consortium with Nestlé Waters, PepsiCo and Suntory Beverage & Food
Biotech SME Awards 2019: Recognising breakthrough science in Europe
ABIVAX Reports Impressive 12-month Efficacy and Safety Data from ABX464 Ulcerative Colitis Maintenance Study at United European Gastroenterology Conference
Impressive 12-month Efficacy and Safety Data from ABX464
FDA approval to launch a clinical feasibility study in the United States
Inclusion of the first patient in Abivax's Phase 2b (ABX464-103) clinical trial for the treatment of hemorrhagic rectocolitis
